# ARKgen BioScions

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/arkgen-bioscions

- Industry: Biotechnology
- Headquarters: Daejeon, South Korea
- Website: www.arkgenbio.com
- Total disclosed funding: $6.6M
- Latest round: Series A (Jul 13, 2026)
- Investors on record: 12

## About

Based in Seoul, South Korea, and founded in 2021, ARKgen BioScions Inc. operates as a biopharmaceutical company that develops immuno-anticancer drugs using a multi-antibody platform. In July 2026, ARKgen BioScions Inc. raised KRW 10 billion in series A funding from new investor Industrial Bank of Korea, IBK Venture Investment, The Iroun Partners, Scale Up Partners, Korea Credit Guarantee Fund, IMM Investment, WOORI Venture Partners, Korea Innovative Medicines Consortium, Yuanta Investment, and Huons. Returning investor Mirae Holdings also participated in this round.

ARKgen BioScions Inc. offers a pipeline of products that provides solutions for previously challenging medical indications. The company specializes in developing advanced solutions that harness the power of genetic research, bioinformatics, and molecular biology. These solutions cater to a diverse range of applications, from drug discovery and development to precision medicine and agricultural biotechnology. 

The company will use the July 2026 funding to advance its multi-antibody platform, pipeline research and development, and business development.

## Funding rounds

- Series A, Jul 13, 2026, $6.6M — WOORI Venture Partners, Industrial Bank of Korea, Yuanta Investment, IMM Investment, Korea Credit Guarantee Fund, Mirae Holdings, Scale Up Partners, Huons, IBK Venture Investment, Korea Innovative Medicines Consortium
- Seed, Dec 26, 2023 — Bluepoint Partners, Korea Tech Incubator for Startup

## Investors

- Bluepoint Partners (https://capitalatlas.ai/funds/bluepoint-partners) — Seed
- Korea Tech Incubator for Startup — Seed
- WOORI Venture Partners (https://capitalatlas.ai/funds/woori-venture-partners) — Series A
- Industrial Bank of Korea — Series A
- Yuanta Investment (https://capitalatlas.ai/funds/yuanta-investment) — Series A
- IMM Investment (https://capitalatlas.ai/funds/imm-investment) — Series A
- Korea Credit Guarantee Fund — Series A
- Mirae Holdings (https://capitalatlas.ai/funds/mirae-holdings) — Series A
- Scale Up Partners (https://capitalatlas.ai/funds/scale-up-partners) — Series A
- Huons — Series A
- IBK Venture Investment (https://capitalatlas.ai/funds/ibk-venture-investment) — Series A
- Korea Innovative Medicines Consortium — Series A